Literature DB >> 26109664

Glial Expression of the Caenorhabditis elegans Gene swip-10 Supports Glutamate Dependent Control of Extrasynaptic Dopamine Signaling.

J Andrew Hardaway1, Sarah M Sturgeon1, Chelsea L Snarrenberg1, Zhaoyu Li2, X Z Shawn Xu2, Daniel P Bermingham1, Peace Odiase3, W Clay Spencer4, David M Miller4, Lucia Carvelli5, Shannon L Hardie1, Randy D Blakely6.   

Abstract

Glial cells play a critical role in shaping neuronal development, structure, and function. In a screen for Caenorhabditis elegans mutants that display dopamine (DA)-dependent, Swimming-Induced Paralysis (Swip), we identified a novel gene, swip-10, the expression of which in glia is required to support normal swimming behavior. swip-10 mutants display reduced locomotion rates on plates, consistent with our findings of elevated rates of presynaptic DA vesicle fusion using fluorescence recovery after photobleaching. In addition, swip-10 mutants exhibit elevated DA neuron excitability upon contact with food, as detected by in vivo Ca(2+) monitoring, that can be rescued by glial expression of swip-10. Mammalian glia exert powerful control of neuronal excitability via transporter-dependent buffering of extracellular glutamate (Glu). Consistent with this idea, swip-10 paralysis was blunted in mutants deficient in either vesicular Glu release or Glu receptor expression and could be phenocopied by mutations that disrupt the function of plasma membrane Glu transporters, most noticeably glt-1, the ortholog of mammalian astrocytic GLT1 (EAAT2). swip-10 encodes a protein containing a highly conserved metallo-β-lactamase domain, within which our swip-10 mutations are located and where engineered mutations disrupt Swip rescue. Sequence alignments identify the CNS-expressed gene MBLAC1 as a putative mammalian ortholog. Together, our studies provide evidence of a novel pathway in glial cells regulated by swip-10 that limits DA neuron excitability, DA secretion, and DA-dependent behaviors through modulation of Glu signaling.
Copyright © 2015 the authors 0270-6474/15/359409-15$15.00/0.

Entities:  

Keywords:  C. elegans; dopamine; glia; glutamate; transporters

Mesh:

Substances:

Year:  2015        PMID: 26109664      PMCID: PMC4478255          DOI: 10.1523/JNEUROSCI.0800-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  68 in total

1.  One GABA and two acetylcholine receptors function at the C. elegans neuromuscular junction.

Authors:  J E Richmond; E M Jorgensen
Journal:  Nat Neurosci       Date:  1999-09       Impact factor: 24.884

Review 2.  Is there a common molecular pathway for addiction?

Authors:  Eric J Nestler
Journal:  Nat Neurosci       Date:  2005-11       Impact factor: 24.884

Review 3.  ADHD and the dopamine transporter: are there reasons to pay attention?

Authors:  M S Mazei-Robinson; R D Blakely
Journal:  Handb Exp Pharmacol       Date:  2006

Review 4.  Deciphering the neural and molecular mechanisms of C. elegans behavior.

Authors:  William R Schafer
Journal:  Curr Biol       Date:  2005-09-06       Impact factor: 10.834

5.  Molecular characterization of the metabotropic glutamate receptor family in Caenorhabditis elegans.

Authors:  J Dillon; N A Hopper; L Holden-Dye; V O'Connor
Journal:  Biochem Soc Trans       Date:  2006-11       Impact factor: 5.407

6.  A C. elegans stretch receptor neuron revealed by a mechanosensitive TRP channel homologue.

Authors:  Wei Li; Zhaoyang Feng; Paul W Sternberg; X Z Shawn Xu
Journal:  Nature       Date:  2006-03-30       Impact factor: 49.962

7.  C. elegans daf-6 encodes a patched-related protein required for lumen formation.

Authors:  Elliot A Perens; Shai Shaham
Journal:  Dev Cell       Date:  2005-06       Impact factor: 12.270

8.  Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression.

Authors:  Jeffrey D Rothstein; Sarjubhai Patel; Melissa R Regan; Christine Haenggeli; Yanhua H Huang; Dwight E Bergles; Lin Jin; Margaret Dykes Hoberg; Svetlana Vidensky; Dorothy S Chung; Shuy Vang Toan; Lucie I Bruijn; Zao-Zhong Su; Pankaj Gupta; Paul B Fisher
Journal:  Nature       Date:  2005-01-06       Impact factor: 49.962

9.  Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation.

Authors:  Kon Chu; Soon-Tae Lee; Dong-In Sinn; Song-Yi Ko; Eun-Hee Kim; Jeong-Min Kim; Se-Jeong Kim; Dong-Kyu Park; Keun-Hwa Jung; Eun-Cheol Song; Sang Kun Lee; Manho Kim; Jae-Kyu Roh
Journal:  Stroke       Date:  2006-11-22       Impact factor: 7.914

10.  Polyadenylation factor CPSF-73 is the pre-mRNA 3'-end-processing endonuclease.

Authors:  Corey R Mandel; Syuzo Kaneko; Hailong Zhang; Damara Gebauer; Vasupradha Vethantham; James L Manley; Liang Tong
Journal:  Nature       Date:  2006-11-26       Impact factor: 49.962

View more
  16 in total

1.  Swimming Induced Paralysis to Assess Dopamine Signaling in Caenorhabditis elegans.

Authors:  Sirisha Kudumala; Serena Sossi; Lucia Carvelli
Journal:  J Vis Exp       Date:  2019-04-03       Impact factor: 1.355

2.  Blockade and reversal of swimming-induced paralysis in C. elegans by the antipsychotic and D2-type dopamine receptor antagonist azaperone.

Authors:  Osama Refai; Randy D Blakely
Journal:  Neurochem Int       Date:  2018-05-22       Impact factor: 3.921

3.  The Atypical MAP Kinase SWIP-13/ERK8 Regulates Dopamine Transporters through a Rho-Dependent Mechanism.

Authors:  Daniel P Bermingham; J Andrew Hardaway; Osama Refai; Christian R Marks; Sam L Snider; Sarah M Sturgeon; William C Spencer; Roger J Colbran; David M Miller; Randy D Blakely
Journal:  J Neurosci       Date:  2017-08-21       Impact factor: 6.167

4.  Acute blockade of the Caenorhabditis elegans dopamine transporter DAT-1 by the mammalian norepinephrine transporter inhibitor nisoxetine reveals the influence of genetic modifications of dopamine signaling in vivo.

Authors:  Daniel P Bermingham; J Andrew Hardaway; Chelsea L Snarrenberg; Sarah B Robinson; Oakleigh M Folkes; Greg J Salimando; Hussain Jinnah; Randy D Blakely
Journal:  Neurochem Int       Date:  2016-02-03       Impact factor: 3.921

5.  Sequence determinants of the Caenhorhabditis elegans dopamine transporter dictating in vivo axonal export and synaptic localization.

Authors:  Sarah B Robinson; J Andrew Hardaway; Shannon L Hardie; Jane Wright; Ryan M Glynn; Daniel P Bermingham; Qiao Han; Sarah M Sturgeon; Phyllis Freeman; Randy D Blakely
Journal:  Mol Cell Neurosci       Date:  2016-11-30       Impact factor: 4.314

6.  Allosteric Modulator KM822 Attenuates Behavioral Actions of Amphetamine in Caenorhabditis elegans through Interactions with the Dopamine Transporter DAT-1.

Authors:  Osama Refai; Shaili Aggarwal; Mary Hongying Cheng; Zayna Gichi; Joseph M Salvino; Ivet Bahar; Randy D Blakely; Ole V Mortensen
Journal:  Mol Pharmacol       Date:  2021-12-14       Impact factor: 4.436

7.  Serotonin and dopamine modulate aging in response to food odor and availability.

Authors:  Hillary A Miller; Shijiao Huang; Elizabeth S Dean; Megan L Schaller; Angela M Tuckowski; Allyson S Munneke; Safa Beydoun; Scott D Pletcher; Scott F Leiser
Journal:  Nat Commun       Date:  2022-06-07       Impact factor: 17.694

Review 8.  Cell-type-specific promoters for C. elegans glia.

Authors:  Wendy Fung; Leigh Wexler; Maxwell G Heiman
Journal:  J Neurogenet       Date:  2020-07-22       Impact factor: 1.250

9.  Global untargeted serum metabolomic analyses nominate metabolic pathways responsive to loss of expression of the orphan metallo β-lactamase, MBLAC1.

Authors:  Chelsea L Gibson; Simona G Codreanu; Alexandra C Schrimpe-Rutledge; Cassandra L Retzlaff; Jane Wright; Doug P Mortlock; Stacy D Sherrod; John A McLean; Randy D Blakely
Journal:  Mol Omics       Date:  2018-06-12

10.  Inferences of glia-mediated control in Caenorhabditis elegans.

Authors:  Stephanie N Bowles; Casonya M Johnson
Journal:  J Neurosci Res       Date:  2021-02-08       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.